New blood test could spot spread of rare eye cancer

NCT ID NCT01334008

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to develop a blood test that can detect tiny bits of tumor DNA in patients with metastatic choroidal melanoma, a rare eye cancer that has spread. Researchers tested blood samples from 40 adults to see if the test could reliably find cancer DNA. The goal was to create a simpler way to monitor the disease without needing repeated tissue biopsies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA, DIFFUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Curie

    Paris, 75005, France